Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin for Prevention of Pancreatic Fistula After Pancreaticoduodenectomy
NCT03349424Phase 4Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2018
- Primary completion
- May 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of somatostatin in pancreatic fistula (POPF), sponsored by Peking Union Medical College Hospital. Started Jun 2018; status: completed.
02
Drugs
somatostatin
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT03349424.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349424.